Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer

First Page		Document Content
Date: 2014-09-11 11:59:08		Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer Add to Reading List Source URL: www.vaxira.com Download Document from Source Website File Size: 966,00 KB Share Document on Facebook